Insider · CIK 0001253803

Cerrone Gabriel

CIK 0001253803 Name as filed on the most recent filing

Filed as Cerrone Gabriel (21)

25 transaction lines · from 21 filings · filed 2004-12-07 to 2013-10-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

25 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2013-10-29 P, Open-market purchase Synergy Pharmaceuticals, Inc.SGYP 49,080, acquired Open Form 4 filing 0001104659-13-078633
2013-06-14 P, Open-market purchase Synergy Pharmaceuticals, Inc.SGYP 35,360, acquired Open Form 4 filing 0001104659-13-049229
2013-04-24 P, Open-market purchase Synergy Pharmaceuticals, Inc.SGYP 55,750, acquired Open Form 4 filing 0001104659-13-032037
2013-04-24 P, Open-market purchase Synergy Pharmaceuticals, Inc.SGYP 25,612, acquired Open Form 4 filing 0001104659-13-032075
2013-02-05 P, Open-market purchase Synergy Pharmaceuticals, Inc.SGYP 24,711, acquired Open Form 4 filing 0001104659-13-007379
2013-02-04 P, Open-market purchase Synergy Pharmaceuticals, Inc.SGYP 79,035, acquired Open Form 4 filing 0001104659-13-007045
2013-02-04 P, Open-market purchase Synergy Pharmaceuticals, Inc.SGYP 6,040, acquired Open Form 4 filing 0001104659-13-007379
2013-01-30 P, Open-market purchase Synergy Pharmaceuticals, Inc.SGYP 2 lines 155,544, acquired Open Form 4 filing 0001104659-13-006700
2012-12-10 P, Open-market purchase TrovaGene Inc.TROV Not reported Open Form 4 filing 0001104659-12-084986
2012-11-14 P, Open-market purchase Synergy Pharmaceuticals, Inc.SGYP 317,250, acquired Open Form 4 filing 0001104659-12-078129
2012-08-20 P, Open-market purchase TrovaGene Inc.TROV 17,700, acquired Open Form 4 filing 0001104659-12-058850
2012-08-17 P, Open-market purchase TrovaGene Inc.TROV 645, acquired Open Form 4 filing 0001104659-12-058850
2012-08-16 P, Open-market purchase TrovaGene Inc.TROV 33,632, acquired Open Form 4 filing 0001104659-12-058599
2012-04-13 P, Open-market purchase TrovaGene Inc.TROV 100,000, acquired Open Form 4 filing 0001104659-12-025725
2011-11-14 P, Open-market purchase Synergy Pharmaceuticals, Inc.SGYP 1,000,000, acquired Open Form 4 filing 0001104659-11-064130
2010-11-15 P, Open-market purchase Callisto Pharmaceuticals IncCLSP Not reported Open Form 4 filing 0001104659-10-058934
2005-06-09 P, Open-market purchase Callisto Pharmaceuticals IncKAL 5,000, acquired Open Form 4 filing 0001321543-05-000004
2005-06-03 P, Open-market purchase Callisto Pharmaceuticals IncKAL Not reported Open Form 4 filing 0000930413-05-004182
2005-06-03 P, Open-market purchase Callisto Pharmaceuticals IncKAL 6,120, acquired Open Form 4 filing 0000930413-05-004145
2005-05-27 P, Open-market purchase Callisto Pharmaceuticals IncKAL 7,976, acquired Open Form 4 filing 0000930413-05-004103
2005-05-19 P, Open-market purchase Callisto Pharmaceuticals IncKAL 12,750, acquired Open Form 4 filing 0000930413-05-003756
2005-03-09 P, Open-market purchase Callisto Pharmaceuticals IncKAL 38,000, acquired Open Form 4 filing 0000930413-05-001786
2004-12-03 P, Open-market purchase Callisto Pharmaceuticals IncKAL 2 lines 40,700, acquired Open Form 4 filing 0001125282-04-006100

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
*, Other
Other
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 25
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. CERRONE GABRIEL, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001253803

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.